Outstanding announcement and its non exclusive. Sanofi really have been preparing well for the new biologics market and others will have a lot of thinking to do. That's a lot of revenue $50M cash for customisation then 6 x 5m units a year at $25. Do I read that right? It had to happen after they gave themselves priced shares but didn't expect it this soon. Sweeet!!